MedPath

The Effect of Remimazolam on Postoperative Sleep Quality

Not Applicable
Not yet recruiting
Conditions
Gynecological Day Surgery
Interventions
Registration Number
NCT07094945
Lead Sponsor
Tongji Hospital
Brief Summary

A large amount of clinical evidence shows that after surgery, especially major surgery, the sleep quality of patients often drops significantly immediately, with the most obvious decline on the first night after surgery, which can last for several days to several months. Remimazolam is a new type of benzodiazepine drug and a super-short-acting GABAA receptor agonist. Compared with propofol, remimazolam can largely avoid adverse reactions such as hemodynamic fluctuations, excessive sedation and injection pain caused by propofol. It has good safety and is superior to propofol. However, there are currently only a few clinical research results regarding the impact of remimazolam on the sleep quality of patients under general anesthesia or sedation. Therefore, this study intends to observe the effect of remimazolam on the sleep quality of patients in gynecological day surgery. It is expected that by optimizing the anesthesia plan, the postoperative sleep quality of patients can be improved, and ultimately the postoperative recovery of patients can be promoted.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
260
Inclusion Criteria
  • ASA classification grades I - II.
  • BMI: 18.5-24 kg/m ².
  • Be able to correctly understand and complete the assessment scale independently.
  • The operation time shall not exceed one hour.
  • Informed consent for this research.
Exclusion Criteria
  • PSQI > 7 points (with sleep disorders requiring medical intervention within the last month).
  • Suffering from central nervous system diseases or mental disorders.
  • Patients with sleep apnea syndrome or other serious respiratory diseases.
  • Have functional disorders of important organs.
  • Alcohol abuse or a history of opioid, benzodiazepine or other known drug abuse that may affect sleep.
  • Allergic to the research medication.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remimazolam GropRemimazolamRemimazolam 0.3mg/kg for induction and 0.6-1.0 mg/kg·h for maintenance of anesthesia
Propofol GroupPropofolPropofol 2 mg/kg for induction and 4-12 mg/kg·h for maintenance of anesthesia
Primary Outcome Measures
NameTimeMethod
Richard Campbell's Sleep Scale scoreThe night of the first to third postoperative day

Range: 0 points (optimal sleep) to 10 points (optimal sleep). Direction: The higher the score, the more severe the sleep problem

Secondary Outcome Measures
NameTimeMethod
Blood PressureBefore anesthesia, before the insertion of the laryngeal mask, at the beginning of the operation, at the end of the operation, and when the laryngeal mask is removed
Heart rateBefore anesthesia, before the insertion of the laryngeal mask, at the beginning of the operation, at the end of the operation, and when the laryngeal mask is removed.
Postoperative adverse reactions24 hours after the operation

such as postoperative pain, nausea, vomiting, and fatigue.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.